Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryJune 26, 2026

Jails Face Medetomidine-Laced Opioid Withdrawal Crisis Without Treatment Protocols

Correctional facilities are increasingly encountering severe withdrawal cases from opioids contaminated with medetomidine, a veterinary sedative, but lack established treatment protocols for this emerging threat. The drug causes life-threatening withdrawal symptoms distinct from traditional opioid withdrawal, including extreme cardiovascular instability. Jails serve as unintentional frontline medical facilities as individuals enter custody experiencing these dangerous withdrawal episodes. Many facilities remain unprepared with limited access to specialized medical staff or evidence-based treatment approaches for this substance combination.

Why it mattersMedicaid managed care organizations will face coverage and care coordination obligations for justice-involved individuals experiencing medetomidine-complicated withdrawal upon community reentry, requiring protocols for addressing non-standard substance use disorders and potential high-acuity medical needs.

Behavioral Health · Managed Care

Read the full article at statnews.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.